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EFFICACY OF MK-401 (4-AMIN0-6 TRICHLOROETHENYL-1,3 
BENZENEDISULFONMIDE) AGAINST FASCIOLA HEPATICA IN 
ARTIFICIALLY INFECTED CALVES1•2 
Fascioliasis is one of t he important parasitic diseases affecting catt le 
in Puerto Rico~ . 
Control of fascioliasis is directed towards t he destruction of t he snail 
intermediate host, Lymnaea cubensis, and its habitat4 • In Puerto Rico, 
areas of f1at and poorly drained pasturelands where water accumulates 
during the rainy season, and high ambient temperatures combine with 
high rain-fall and humidity to make control of fascioliasis in grazing 
cattle extremely difficult are common. In addition, the ability of the 
snails to undergo cryptobiosis or aestivation presents a difficult problem. 
MK-401 (4-amino-6 trichloroethenyl-1, 3 benzenedisulfonamide) , a 
recently developed benzenedisulfonamide, is reported to be effective 
against mature and immature F. hepatica worms, while having a wide 
margin of safety". De Leon and Quinones6 reported that MK-401 at the 
rates of 6 and 12 mg/kg body weight had a 100% efficacy against 8-week 
old F. hepatica. T he present study was undertaken to further evaluate 
MK-401 at t he dosage rate of 7 mg/ kg body weight. 
Twenty-one Holstein-Friesian/Brown Swiss male calves (approxi-
mately 3 months old) from the Lajas Experiment Station herd, were 
brought to the Gurabo Experiment Station. Each calf was identified by 
a numbered ear tag and a colored neck chain. 
T he animals were examined for ectoparasites and treated orally with 
t hiabendazole for gastrointestinal parasites. Twenty calves (10 replicates 
of 2) used in this study were kept indoors in individual raised cages 
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during the preliminary period and until the second week following 
treatment. The large size of the calves at this time made it necessary to 
place them in a F. hepatica-free pen for the final 7 days prior to slaughter. 
The calves were fed hay and concentrates free choice during the entire 
period of observation. Water was continuously available in buckets and 
was changed twice daily. 
On March 9, 1982, 10 weeks before treatment, each calf was given 
orally, via balling gun, a sealed gelatin capsule that contained about 500 
F. hepatica metacercariae. 
Ten weeks after infection, 1 day before treatment, the calves were 
weighed and grouped by weight into pairs. The two calves of each pair 
were arbitrarily allocated to either the MK-401 or the placebo treatment, 
these being designated as the red and green groups, respectively. The 
pens and neck chains were identified with these colors. The two treat-
ments were as follows: 
1. A single dose of L-631,529-09N-A03, Vehicle, .083 ml/ kg body 
weight orally (green group). 
2. A single dose of L-631,529-13E01-MK-401, 7.0 mg/kg body weight 
orally (red group). 
The treatments were administered May 18, 1982, 10 weeks after 
artificial infection. 
On June 1, 1982, 2 weeks post-treatment and 12 weeks post-metacer-
cariae infection, the calves were slaughtered. The livers were removed 
and identified and the bile conducts opened and examined for liver flukes. 
The livers were then cut into small pieces of about 7.5 to 10 em 
dimensions and placed in warm physiological saline solution. After 30 
minutes the liver tissue was removed from the container and discarded. 
The physiological saline solution was filtered through a 40 mesh sieve 
and the fluke and fluke fragments (heads and tails) were collected and 
counted. 
Fluke counts were obtained by adding the number of heads or tails, 
whichever was bigger, to the number of whole flukes found. 
The section of duodenum into which the bile duct enters was removed, 
the ends tied and the contents examined for adult F. hepatica. 
The carcass remains were saturated with creolin and buried. 
Total fluke counts per animal were transformed to the natural loga-
rithm of (count + 1) for calculation of geometric means and percent 
efficacy. The two groups were compared with the Wilcoxon rank-sum 
statistic in a randomization procedure which leads to an exact probability 
of finding a test statistic as extreme as or more extreme than the one 
observed. A two-sided significance level of .05 was used. 
Fasciola hepatica eggs were detected in the feces of some of the calves 
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at 5 weeks after infection with metacercariae, however, treatment was 
delayed until 10 weeks post infection, at which time all the animals had 
a significant fecal egg populations. Fourteen days after treatment, F. 
hepatica eggs were detected in the feces of only 11% (1/9) of the MK-
401 treated animals, compared to 70% (7 /10) of the vehicle treated 
controls. At necropsy, moderate to severe F. hepatica infestation was 
observed in 100% ( 10/ 10) of the livers from the control group, while 90% 
(9/10) of the livers from the MK-401 treated group (7.0 mg/kg body 
weight) were parasite-free. Two flukes were found in the liver of one of 
the latter animals. The diaphragmatic lobe of the liver from another 
MK-401 treated animal contained an abscess approximately 5.0 em in 
diameter, but there is no reason to incriminate the drug in the pathogen-
esis of this abscess. 
Significantly (P = .01) fewer flukes were recovered from MK-401 
treated animals than from the controls. The percent efficacy of this drug 
was 99.2. 
No adverse clinical signs were observed in either group of animals. 
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